Methods and compositions for treating mast cell gastritis, mast cell esophagitis, mast cell enteritis, mast cell duodenal inflammation, and / or mast cell gastroenteritis.

摘要

The present disclosure provides methods for the treatment of mast cell gastritis, mast cell esophagitis, mast cell colitis, mast cell enteritis, mast cell duodenal inflammation, and / or mast cell gastroenteritis. In particular, the present disclosure discloses mast cell gastritis, mast cell esophagitis, mast cell colitis, mast cell enteritis, mast cell type by administration of an antibody that binds to human Sigma-8 or a composition containing the antibody. Provided are methods for the treatment of duodenal inflammation and / or mast cell gastritis. The present disclosure discloses human Sigma-8 for the treatment of mast cell gastritis, mast cell esophagitis, mast cell colitis, mast cell enteritis, mast cell duodenal inflammation, and / or mast cell gastroenteritis. Also provided are products or kits containing antibodies that bind to.